158 related articles for article (PubMed ID: 14695784)
1. Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis.
Qin RY; Fang RL; Gupta MK; Liu ZR; Wang DY; Chang Q; Chen YB
World J Gastroenterol; 2004 Jan; 10(1):132-5. PubMed ID: 14695784
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
[TBL] [Abstract][Full Text] [Related]
4. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
6. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hua Z; Zhang YC; Hu XM; Jia ZG
World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
[TBL] [Abstract][Full Text] [Related]
7. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
9. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis.
van Heek T; Rader AE; Offerhaus GJ; McCarthy DM; Goggins M; Hruban RH; Wilentz RE
Am J Clin Pathol; 2002 May; 117(5):755-65. PubMed ID: 12090425
[TBL] [Abstract][Full Text] [Related]
10. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.
Moore PS; Sipos B; Orlandini S; Sorio C; Real FX; Lemoine NR; Gress T; Bassi C; Klöppel G; Kalthoff H; Ungefroren H; Löhr M; Scarpa A
Virchows Arch; 2001 Dec; 439(6):798-802. PubMed ID: 11787853
[TBL] [Abstract][Full Text] [Related]
11. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934
[TBL] [Abstract][Full Text] [Related]
12. mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer.
Shahbaz M; Ruliang F; Xu Z; Benjia L; Cong W; Zhaobin H; Jun N
World J Surg Oncol; 2015 Feb; 13():46. PubMed ID: 25890201
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between Gli1 expression and clinicopathological significance in human pancreatic cancer].
Sheng WW; Dong M; Zhou JP; Liu QF; Li X; Dong Q
Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):916-21. PubMed ID: 24433772
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis.
Lüttges J; Galehdari H; Bröcker V; Schwarte-Waldhoff I; Henne-Bruns D; Klöppel G; Schmiegel W; Hahn SA
Am J Pathol; 2001 May; 158(5):1677-83. PubMed ID: 11337365
[TBL] [Abstract][Full Text] [Related]
15. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
[TBL] [Abstract][Full Text] [Related]
16. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
18. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
[TBL] [Abstract][Full Text] [Related]
20. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]